Hepatitis A



Anti-Hepatitis A Virus, Pharmacokinetics, and Safety of Immune Globulin (Human)


Condition:   Anti-Hepatitis A Antibody Levels in Heathy Subjects
Intervention:   Biological: Immune Globulin (Human)
Sponsor:   Grifols Therapeutics Inc.
Recruiting


Hepatitis C Screening in the Primary Care Setting


Condition:   Hepatitis C
Intervention:   Diagnostic Test: Hepatitis C Antibody
Sponsor:   New York Institute of Technology
Completed


HepNet Pilot Trial: Multicenter Trial for the Treatment of Chronic Hepatitis E With Sofosbuvir (SofE)


Conditions:   Hepatitis E;   Hepatitis Chronic Viral
Intervention:   Drug: Sofosbuvir
Sponsors:   Hannover Medical School;   HepNet Study House, German Liverfoundation;   Gilead Sciences;   German Center for Infection Research
Recruiting


Comparative Immunogenicity Study of Two Hepatitis A Vaccines


Condition:   Hepatitis A
Intervention:   Biological: Hepatitis A Vaccine
Sponsors:   China National Biotec Group Company Limited;   Shanxi Provincial Center for Disease Control and Prevention (China)
Enrolling by invitation


Rapid Point-of-care Testing for Hepatitis C in Community Clinics (RAPID-EC)


Condition:   Hepatitis C
Interventions:   Device: OraQuick HCV Ab test;   Device: Xpert HCV viral load test
Sponsors:   Macfarlane Burnet Institute for Medical Research and Public Health Ltd;   Gilead Sciences
Recruiting



A Study on the Recombinant Hepatitis E Vaccine (Escherichia Coli) (Accelerated Vaccination Schedule)


Condition:   Hepatitis E
Intervention:   Biological: Recombinant Hepatitis E Vaccine (Escherichia Coli)
Sponsor:   Xiamen Innovax Biotech Co., Ltd
Active, not recruiting


Hepatitis c and Vitamin D and Iron Status


Condition:   Hepatitis C
Interventions:   Drug: Sofosbuvir 400 mg;   Drug: Daclatasvir 60 mg/day
Sponsor:   Eman Sayed Hassan Abd Allah
Not yet recruiting


Corticosteroids in Alcoholic Hepatitis


Condition:   Alcoholic Hepatitis
Intervention:   Drug: Methylprednisolone or placebo
Sponsor:   Erasme University Hospital
Not yet recruiting


Tenofovir in Early Pregnancy to Prevent Mother-to-child Transmission of Hepatitis B Virus


Condition:   Hepatitis B
Intervention:   Drug: Tenofovir Disoproxil Fumarate
Sponsors:   Johns Hopkins Bloomberg School of Public Health;   Thrasher Research Fund;   Shoklo Malaria Research Unit;   Chiang Mai University;   University of Oxford
Not yet recruiting


This Study Will Evaluate the Persistence of Hepatitis A Antibodies, 8 Years and 10 Years Later, in Children Who Had Received Havrix at Selected Health Centres of Panama in 2007-2008


Condition:   Hepatitis A Vaccine
Intervention:   Procedure: Blood sample collection
Sponsor:   GlaxoSmithKline
Recruiting



The Prime Study - Comparing Hepatitis C Care and Treatment in a Primary Health Care Service With a Tertiary Hospital


Condition:   Hepatitis C
Intervention:   Other: community based hepatitis C care and treatment
Sponsors:   Macfarlane Burnet Institute for Medical Research and Public Health Ltd;   St Vincent's Hospital Melbourne
Recruiting


Reversal of Hepatic Impairment in Patients With Hepatitis C Virus (HCV) and Early Decompensation of Cirrhosis


Condition:   Hepatitis C
Interventions:   Drug: Simeprivir (SMV);   Drug: Sofosbuvir (SOF);   Drug: Ribavirin (RBV)
Sponsors:   University of Colorado, Denver;   Janssen Scientific Affairs, LLC
Active, not recruiting


The Hepatitis Delta International Network


Condition:   Hepatitis D
Intervention:  
Sponsors:   HepNet Study House, German Liverfoundation;   German Center for Infection Research
Recruiting


Immune Cell Dysfunction in Severe Alcoholic Hepatitis


Condition:   Hepatitis
Intervention:  
Sponsor:   Basildon and Thurrock University Hospitals NHS Foundation Trust
Recruiting


Hepatitis B Research Network Pediatric Cohort Study (HBRN)


Condition:   Hepatitis B
Intervention:  
Sponsors:   University of Pittsburgh;   National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Active, not recruiting


Analysis of Trends Over Time of Hepatitis Related Incidence in Panama


Condition:   Hepatitis
Intervention:   Other: Epidemiologic Surveillance System of the Ministry of Health of Panama
Sponsor:   GlaxoSmithKline
Completed


A Study of 2 Doses of VAQTA™ in Healthy Children 12 to 23 Months of Age (V251-069)


Condition:   Hepatitis A Virus Infection
Intervention:   Biological: Hepatitis A Vaccine, Purified Inactivated (VAQTA™)
Sponsor:   Merck Sharp & Dohme Corp.
Completed


Study to Show That the Combined Hepatitis A and B Vaccine is Non-inferior to Monovalent Vaccines in Adults


Conditions:   Hepatitis B;   Hepatitis A
Interventions:   Biological: Twinrix;   Biological: Engerix-B;   Biological: Havrix;   Biological: HBVAXPRO;   Biological: Vaqta
Sponsor:   GlaxoSmithKline
Completed


Concomitant Use of Hepatitis A Vaccine With Measles, Mumps, Rubella and Varicella Vaccine and Pneumococcal 7-Valent Conjugate Vaccine in Healthy 12-Month-Old Children (V251-067)


Condition:   Hepatitis A Virus
Interventions:   Biological: Comparator: VAQTA™ (Hepatitis A vaccine);   Biological: Comparator: ProQuad™ (Measles, Mumps, Rubella and Varicella vaccine);   Biological: Comparator: Prevnar™ (Pneumococcal 7-Valent Conjugate vaccine)
Sponsor:   Merck Sharp & Dohme Corp.
Completed


Long-Term Immune Persistence of GlaxoSmithKline Biologicals' Inactivated Hepatitis A Vaccine Injected According to a 0, 12-month Schedule


Condition:   Hepatitis A
Intervention:   Biological: Havrix™
Sponsor:   GlaxoSmithKline
Completed


Concomitant Use of Hepatitis A Vaccine, Inactivated With Haemophilus b Conjugate Vaccine (Meningococcal Protein Conjugate) and Diphtheria and Tetanus Toxoids and Acellular Pertussis Vaccine Adsorbed Given to Healthy Children 15 Months of Age (V251-068)


Condition:   Hepatitis A Virus
Interventions:   Biological: Comparator: VAQTA™;   Biological: Comparator: Infanrix™;   Biological: Comparator: PedvaxHIB™
Sponsor:   Merck Sharp & Dohme Corp.
Completed


Immune Response & Safety of a Hepatitis A Vaccine Given Together With a Pneumococcal Vaccine in Healthy Children 15 m of Age


Condition:   Hepatitis A
Intervention:   Biological: Hepatitis A
Sponsor:   GlaxoSmithKline
Completed


Immunogenicity and Safety of Havrix™ Co-Administered With a Diphtheria, Tetanus and Pertussis and a Haemophilus b Vaccine in Children Aged 15 Months


Condition:   Hepatitis A
Interventions:   Biological: Havrix™;   Biological: Infanrix™;   Biological: ActHIB™
Sponsor:   GlaxoSmithKline
Completed

Refine Your Search Advanced Search